LivaNova

LivaNova LIVN Stock

$92.90   1.066148%
Add to favorites
Market Cap
$5.12B
LOW - HIGH [24H]
$90.20 - $93.36
VOLUME [24H]
$26.80K
P/E Ratio
26.61
Earnings per share
$3.49
ISIN
GB00BYMT0J19
Price   Prediction

LivaNova Price Chart

Sorry, that's all we've gotfor now...

LivaNova (LIVN) stock price today is 92.9 USD on Tech Market Large (+1.07% on the day). Updated .

LivaNova LIVN Financial and Trading Overview

LivaNova stock price 92.9 USD
Previous Close 92.44 USD
Open 92.73 USD
Bid 67 USD x 200
Ask 118.74 USD x 200
Day's Range 91.63 - 93.64 USD
52 Week Range 53.37 - 99.38 USD
Volume 573.6K USD
Avg. Volume 673.28K USD
Market Cap 5.06B USD
Beta (5Y Monthly) 0.921
PE Ratio (TTM) 26.338108
EPS (TTM) 3.49 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 105.09 USD

LIVN Valuation Measures

Enterprise Value 4.86B USD
Trailing P/E 26.338108
Forward P/E 19.433815
PEG Ratio (5 yr expected) 0.93
Price/Sales (ttm) 3.360231
Price/Book (mrq) 3.6903803
Enterprise Value/Revenue 3.223
Enterprise Value/EBITDA 17.906

Trading Information

LivaNova Stock Price History

Beta (5Y Monthly) 0.921
52-Week Change 70.50%
S&P500 52-Week Change 10.51%
52 Week High 99.38 USD
52 Week Low 53.37 USD
50-Day Moving Average 80.76 USD
200-Day Moving Average 74.44 USD

LIVN Share Statistics

Avg. Volume (3 month) 673.28K USD
Avg. Daily Volume (10-Days) 1.01M USD
Shares Outstanding 55.09M
Float 54.83M
Short Ratio 11.01
% Held by Insiders 0.41%
% Held by Institutions 114.81%
Shares Short 6.36M
Short % of Float 13.26%
Short % of Shares Outstanding 11.55%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 13.01%
Operating Margin (ttm) 14.29%
Gross Margin 67.63%
EBITDA Margin 18.00%

Management Effectiveness

Return on Assets (ttm) 5.10%
Return on Equity (ttm) 15.50%

Income Statement

Revenue (ttm) 1.51B USD
Revenue Per Share (ttm) 27.48 USD
Quarterly Revenue Growth (yoy) 9.90%
Gross Profit (ttm) 1.02B USD
EBITDA 271.27M USD
Net Income Avi to Common (ttm) 196.06M USD
Diluted EPS (ttm) 3.49
Quarterly Earnings Growth (yoy) 28.00%

Balance Sheet

Total Cash (mrq) 563.47M USD
Total Cash Per Share (mrq) 10.23 USD
Total Debt (mrq) 357.07M USD
Total Debt/Equity (mrq) 26.02 USD
Current Ratio (mrq) 1.463
Book Value Per Share (mrq) 24.908

Cash Flow Statement

Operating Cash Flow (ttm) 237.86M USD
Levered Free Cash Flow (ttm) 67.71M USD

Profile of LivaNova

Country United States
State N/A
City Gloucester
Address 5220 Valiant Court
ZIP GL3 4FE
Phone 44 1452 638 500
Website https://www.livanova.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 3300

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.

Q&A For LivaNova Stock

What is a current LIVN stock price?

LivaNova LIVN stock price today per share is 92.9 USD.

How to purchase LivaNova stock?

You can buy LIVN shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for LivaNova?

The stock symbol or ticker of LivaNova is LIVN.

Which industry does the LivaNova company belong to?

The LivaNova industry is Medical Devices.

How many shares does LivaNova have in circulation?

The max supply of LivaNova shares is 55.09M.

What is LivaNova Price to Earnings Ratio (PE Ratio)?

LivaNova PE Ratio is 26.61891200 now.

What was LivaNova earnings per share over the trailing 12 months (TTM)?

LivaNova EPS is 3.49 USD over the trailing 12 months.

Which sector does the LivaNova company belong to?

The LivaNova sector is Healthcare.

LivaNova LIVN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24505.23 USD —
+0.73
2.1B USD — 24268.03 USD — 24538.78 USD — — 2.1B USD —
us US Tech Global Select Market Com NQGS US 12067.97 USD —
+0.7
— — 11954.49 USD — 12087.35 USD — — — —
us US Tech Health Care IXHC US 1333.59 USD —
+0.05
— — 1325.21 USD — 1342.46 USD — — — —
us US Tech Composite Total Return XCMP US 30275.92 USD —
+0.7
— — 29990.36 USD — 30324.94 USD — — — —
$2.19T
Total marketcap
$71.65B
Total volume
BTC 58.25%   •   ETH 9.87%
Dominance
Select currency